186 related articles for article (PubMed ID: 18824719)
1. Bevacizumab in advanced colorectal cancer: a challenge to the current paradigm.
Booth C
J Clin Oncol; 2008 Oct; 26(28):4693-4; author reply 4694-5. PubMed ID: 18824719
[No Abstract] [Full Text] [Related]
2. Dual biologic therapy in the first-line mCRC setting: implications of the CAIRO2 study.
Chu E
Clin Colorectal Cancer; 2008 Jul; 7(4):226. PubMed ID: 18650190
[No Abstract] [Full Text] [Related]
3. [Metastatic colorectal cancer: adjournments from ESMO 2006].
Bonetti A; Cascinu S; Falcone A; Maiello E; Zaniboni A; Aschele C
Tumori; 2006; 92(6):1-12. PubMed ID: 17262903
[No Abstract] [Full Text] [Related]
4. Current role of bevacizumab in colorectal cancer.
Saltz L
Clin Adv Hematol Oncol; 2009 Jun; 7(6):375-6. PubMed ID: 19606071
[No Abstract] [Full Text] [Related]
5. Common side effects and interactions of colorectal cancer therapeutic agents.
Holt K
J Pract Nurs; 2011; 61(1):7-20. PubMed ID: 21751717
[No Abstract] [Full Text] [Related]
6. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Pohlmann PR; Mernaugh RL; Goff LW
N Engl J Med; 2009 May; 360(20):2134; author reply 2135-6. PubMed ID: 19439750
[No Abstract] [Full Text] [Related]
7. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Copur MS; Norvell M; Obermiller A
N Engl J Med; 2009 May; 360(20):2135; author reply 2135-6. PubMed ID: 19445033
[No Abstract] [Full Text] [Related]
8. Highlights from: The 44th Annual Meeting of the American Society of Clinical Oncology. Chicago, IL; May 30-June 3, 2008.
Gibson TB; Grothey E; Chu E
Clin Colorectal Cancer; 2008 Jul; 7(4):233-9. PubMed ID: 18650191
[No Abstract] [Full Text] [Related]
9. Should capecitabine replace infusional fluorouracil and leucovorin when combined with oxaliplatin in metastatic colorectal cancer?
Mayer RJ
J Clin Oncol; 2007 Sep; 25(27):4165-7. PubMed ID: 17709796
[No Abstract] [Full Text] [Related]
10. Update on capecitabine alone and in combination regimens in colorectal cancer patients.
Silvestris N; Maiello E; De Vita F; Cinieri S; Santini D; Russo A; Tommasi S; Azzariti A; Numico G; Pisconti S; Petriella D; Lorusso V; Millaku A; Colucci G
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S46-55. PubMed ID: 21129610
[TBL] [Abstract][Full Text] [Related]
11. [The development of the first line treatment of metastatic colorectal cancer (mCRC)].
Landherr L; Nagykálnai T
Magy Onkol; 2009 Sep; 53(3):237-46. PubMed ID: 19793687
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy with bevacizumab.
Gruenberger T; Gruenberger B; Scheithauer W
J Clin Oncol; 2006 Jun; 24(16):2592-3; author reply 2593-4. PubMed ID: 16735714
[No Abstract] [Full Text] [Related]
13. Chemotherapy and immunotherapy in metastatic colorectal cancer.
Loupakis F; Di Maio M; Falcone A
N Engl J Med; 2009 May; 360(20):2135; author reply 2135-6. PubMed ID: 19445032
[No Abstract] [Full Text] [Related]
14. Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer.
Dohn LH; Jensen BV; Larsen FO
Acta Oncol; 2010 Apr; 49(3):395-6. PubMed ID: 20001495
[No Abstract] [Full Text] [Related]
15. First-line therapeutic strategies in metastatic colorectal cancer.
Davies JM; Goldberg RM
Oncology (Williston Park); 2008 Nov; 22(13):1470-9. PubMed ID: 19133603
[TBL] [Abstract][Full Text] [Related]
16. Medical oncology: A novel low-toxicity regimen for advanced colorectal cancer?
Yanagisawa Y; Midgley RS
Nat Rev Clin Oncol; 2010 Oct; 7(10):556-7. PubMed ID: 20877418
[No Abstract] [Full Text] [Related]
17. [Present status of chemotherapy for colorectal cancer in countries outside of Japan].
Doi T; Ohtsu A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():368-73. PubMed ID: 14574915
[No Abstract] [Full Text] [Related]
18. First-line treatment of advanced colorectal cancer.
Hewish M; Cunningham D
Lancet; 2011 Jun; 377(9783):2060-2. PubMed ID: 21641637
[No Abstract] [Full Text] [Related]
19. Targeted therapy for advanced colorectal cancer--more is not always better.
Mayer RJ
N Engl J Med; 2009 Feb; 360(6):623-5. PubMed ID: 19196680
[No Abstract] [Full Text] [Related]
20. Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study.
Fuchs CS; Marshall J; Barrueco J
J Clin Oncol; 2008 Feb; 26(4):689-90. PubMed ID: 18235136
[No Abstract] [Full Text] [Related]
[Next] [New Search]
